إعلان
إعلان
PCSA
Processa Pharmaceuticals, Inc. Common
3.36
USDبرعاية
-0.10
-2.83%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
3.31
-0.05
-1.55%
تقارير أرباح PCSA
النسبة الإيجابية المفاجئة
PCSA تفوق 7 من 20 آخر التقديرات.
35%
التقرير التالي
بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.40
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-20.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-92.43%
Processa Pharmaceuticals, Inc. Common earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, PCSA reported earnings of -1.75 USD per share (EPS) for Q3 25, beating the estimate of -2.04 USD, resulting in a 14.22% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -3.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -1.40 USD, with revenue projected to reach -- USD, implying an نقصان of -20.00% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Processa Pharmaceuticals, Inc. Common's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Processa Pharmaceuticals, Inc. Common reported EPS of -$1.75, beating estimates by 14.22%, and revenue of --, -- -- expectations.
How did the market react to Processa Pharmaceuticals, Inc. Common's Q3 2025 earnings?
The stock price moved down -3.2%, changed from $7.90 before the earnings release to $7.64 the day after.
When is Processa Pharmaceuticals, Inc. Common expected to report next?
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
What are the forecasts for Processa Pharmaceuticals, Inc. Common's next earnings report?
Based on 4
المحللين, Processa Pharmaceuticals, Inc. Common is expected to report EPS of -$1.40 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان